Online Exposure Therapy for Obsessive-Compulsive Disorder (OCD) Study

University of Miami63 enrolled

Overview

The overarching goal of this protocol is to investigate mechanisms that influence symptom outcomes of exposure and response prevention (ERP) therapy for OCD. Mechanisms may include affective processes, learning factors, cognitive factors, or other constructs that could influence treatment outcomes. The study team will conduct this research within the context of an effective online treatment for OCD called OCD-NET. OCD-NET is bibliotherapy with coaching and its content is reflective of standard care for OCD.

Study Type

INTERVENTIONAL

Allocation

Purpose

BASIC_SCIENCE

Masking

NONE

Enrollment

Conditions

Obsessive-Compulsive Disorder

Interventions

OCD-NETBEHAVIORAL

OCD-NET is bibliotherapy with coaching and its content is reflective of standard care for OCD. OCD-NET is a self-paced intervention that participants complete entirely online with the support of an assigned individual therapist. Most participants complete this treatment in up to twelve weeks. On average, participants are expected to spend between one to five hours per week during the first half of treatment. In the second half of treatment when participants begin regular exposure and response prevention (ERP) exercises, participants are expected to spend about one hour per day.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * English-speaking * Located within the United States * 18-90 years old * Able to provide consent * Current diagnosis of OCD as assessed by clinical interview Exclusion Criteria: * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Participants currently located outside of the United States * Prisoners * Participants with hoarding as the primary OCD symptom * Severe mental illness (e.g. schizophrenia, substance abuse); organic brain syndrome; or serious, current suicidal/homicidal ideation (based on phone screening or initial assessment) * Concurrent enrollment in another psychotherapy treatment * Participants taking psychotropic medication may be excluded if: * They have started a brand new psychotropic medication within the last 12 weeks * They have changed the dose of their psychotropic medication within the last 4 weeks * They anticipate that they cannot maintain the current dose of their psychotropic medication for the duration of the study * Participants may be excluded if they have any cognitive or physical impairments that would interfere with their participation (e.g., significant head injury, cognitive disability, dementia).

Locations (1)

University of Miami

Miami, Florida, United States

Outcomes

Primary Outcomes

Change in OCD Symptoms Measured by Yale-Brown Obsessive Compulsive Scale-Second Edition (YBOCS-II)

YBOCS-II scores range from 0-50, and higher scores indicate more severe illness

Time frame: Baseline, up to 12 months (end of treatment)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.